STOCK TITAN

[Form 4] Trueblue, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

TrueBlue, Inc. insider Jason Embick, Senior Vice President and Chief Accounting Officer, reported a sale of 700 shares of Common Stock on 09/03/2025 at a price of $5.72 per share. After the sale he beneficially owns 33,648 shares directly. The Form 4 was signed by an attorney-in-fact on 09/05/2025.

Jason Embick, Senior Vice President e Chief Accounting Officer di TrueBlue, Inc., ha venduto 700 azioni ordinarie il 03/09/2025 a $5,72 per azione. Dopo la cessione, detiene direttamente beneficiariamente 33.648 azioni. Il Modulo 4 è stato firmato da un procuratore il 05/09/2025.

Jason Embick, Senior Vice President y Chief Accounting Officer de TrueBlue, Inc., comunicó la venta de 700 acciones ordinarias el 03/09/2025 a $5,72 por acción. Tras la operación posee directamente, a título beneficiario, 33.648 acciones. El Formulario 4 fue firmado por un apoderado el 05/09/2025.

TrueBlue, Inc.의 Jason Embick 수석 부사장 겸 최고회계책임자는 2025-09-03보통주 700주를 주당 $5.72에 매도했습니다. 매도 후 그는 직접적으로 수익적 소유자로서 33,648주를 보유하고 있습니다. Form 4는 2025-09-05에 대리인이 서명했습니다.

Jason Embick, Senior Vice President et Chief Accounting Officer de TrueBlue, Inc., a déclaré la vente de 700 actions ordinaires le 03/09/2025 au prix de 5,72 $ par action. Après la vente, il détient directement à titre bénéficiaire 33 648 actions. Le formulaire 4 a été signé par un mandataire le 05/09/2025.

Jason Embick, Senior Vice President und Chief Accounting Officer von TrueBlue, Inc., meldete den Verkauf von 700 Stammaktien am 03.09.2025 zu $5,72 je Aktie. Nach dem Verkauf besitzt er direkt wirtschaftlich 33.648 Aktien. Das Formular 4 wurde am 05.09.2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Insider sale of 700 shares, small relative holding; routine disclosure with limited investor impact.

The reported transaction is a direct sale of 700 TrueBlue shares at $5.72, leaving the reporting person with 33,648 shares. For a company-level assessment this single small sale provides limited insight into company fundamentals or material change in insider alignment. The filing satisfies Section 16 disclosure requirements and contains no derivative activity or additional remarks.

TL;DR Routine officer sale disclosed; no governance red flags or related-party issues disclosed in this Form 4.

The form shows an individual officer executing a non-derivative sale with no accompanying explanations or linked transactions. There is no indication of planned dispositions under a Rule 10b5-1 plan nor of related-party transfers. The filing appears procedurally complete and timely based on the dates supplied.

Jason Embick, Senior Vice President e Chief Accounting Officer di TrueBlue, Inc., ha venduto 700 azioni ordinarie il 03/09/2025 a $5,72 per azione. Dopo la cessione, detiene direttamente beneficiariamente 33.648 azioni. Il Modulo 4 è stato firmato da un procuratore il 05/09/2025.

Jason Embick, Senior Vice President y Chief Accounting Officer de TrueBlue, Inc., comunicó la venta de 700 acciones ordinarias el 03/09/2025 a $5,72 por acción. Tras la operación posee directamente, a título beneficiario, 33.648 acciones. El Formulario 4 fue firmado por un apoderado el 05/09/2025.

TrueBlue, Inc.의 Jason Embick 수석 부사장 겸 최고회계책임자는 2025-09-03보통주 700주를 주당 $5.72에 매도했습니다. 매도 후 그는 직접적으로 수익적 소유자로서 33,648주를 보유하고 있습니다. Form 4는 2025-09-05에 대리인이 서명했습니다.

Jason Embick, Senior Vice President et Chief Accounting Officer de TrueBlue, Inc., a déclaré la vente de 700 actions ordinaires le 03/09/2025 au prix de 5,72 $ par action. Après la vente, il détient directement à titre bénéficiaire 33 648 actions. Le formulaire 4 a été signé par un mandataire le 05/09/2025.

Jason Embick, Senior Vice President und Chief Accounting Officer von TrueBlue, Inc., meldete den Verkauf von 700 Stammaktien am 03.09.2025 zu $5,72 je Aktie. Nach dem Verkauf besitzt er direkt wirtschaftlich 33.648 Aktien. Das Formular 4 wurde am 05.09.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Embick Jason

(Last) (First) (Middle)
1015 A STREET

(Street)
TACOMA WA 98402

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TrueBlue, Inc. [ TBI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/03/2025 F 700 D $5.72 33,648 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Todd N. Gilman, Attorney-in-fact 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Trueblue

NYSE:TBI

TBI Rankings

TBI Latest News

TBI Latest SEC Filings

TBI Stock Data

171.93M
28.35M
4.78%
94.08%
2.61%
Staffing & Employment Services
Services-help Supply Services
Link
United States
TACOMA